aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
BioVascular, Inc. develops and markets cardiovascular therapeutics aimed at improving vascular health. The company focuses on producing drugs and devices that control intimal hyperplasia associated with vascular procedures and address risk factors in cardiovascular morbidity and mortality. BioVascular serves customers throughout the United States, providing innovative solutions to enhance cardiovascular care.
BioVascular has made significant strides in the field of cardiovascular therapeutics, contributing to better patient outcomes through its specialized products. By addressing critical issues in vascular health, the company has positioned itself as a key player in the healthcare industry. Its impact is reflected in the improved quality of life for patients undergoing vascular procedures.
Operating Status
Closed
Ownership Type(s)
Private
Main Product(s)
Therapeutics, Drugs
Technology
Biotech
Tags
Healthtech
Revenue Type(s)
Transactional
Customer Type(s)
Enterprise
Geographic Exposure
United States
When was BioVascular founded?
BioVascular was founded in 2005.
Where is BioVascular's headquarters located?
BioVascular's headquarters is located in San Diego, CA, US.
When was BioVascular's last funding round?
BioVascular's most recent funding round was for $10.9M (USD) in February 2008.
How many employees does BioVascular have?
BioVascular has 3 employees as of Feb 4, 2024.
How much has BioVascular raised to-date?
As of July 05, 2023, BioVascular has raised a total of $10.9M (USD) since Feb 7, 2008.
Add Comparison
Total Raised to Date
$10.9M
USD
Last Update Feb 7, 2008
Last Deal Details
$10.9M
USD
Feb 7, 2008
Series C
Total Employees Over Time
3
As of Feb 2024
BioVascular Address
12230 El Camino Real
Suite 100
San Diego,
California
92130
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts